TWD 11.25
(-0.44%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 973 Thousand TWD | -38.54% |
2022 | 34.43 Million TWD | 79.75% |
2021 | 19.18 Million TWD | -7.35% |
2020 | 20.88 Million TWD | 297.18% |
2019 | -8.23 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -5.14 Million TWD | -15.51% |
2024 Q2 | -5.14 Million TWD | -11.85% |
2023 Q3 | -4.45 Million TWD | -306.21% |
2023 Q1 | 2.15 Million TWD | -65.03% |
2023 FY | - TWD | -38.54% |
2023 Q2 | 2.15 Million TWD | 0.0% |
2023 Q4 | -4.45 Million TWD | 0.0% |
2022 Q4 | 6.17 Million TWD | 0.0% |
2022 FY | - TWD | 79.75% |
2022 Q3 | 6.17 Million TWD | 0.0% |
2021 FY | - TWD | -7.35% |
2020 FY | - TWD | 297.18% |
2019 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
VBI | -6.97 Million TWD | 113.956% |
Enimmune corporation | -228.96 Million TWD | 100.425% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 99.753% |
Level Biotechnology Inc. | 98.7 Million TWD | 99.014% |
Sagittarius Life Science Corp | -44.73 Million TWD | 102.175% |
NeoCore Technology Co., Ltd. | -72.11 Million TWD | 101.349% |
TaiMed Biologics Inc. | -25.23 Million TWD | 103.856% |
GlycoNex Incorporation | -126.82 Million TWD | 100.767% |
GeneReach Biotechnology Corp. | -143.69 Million TWD | 100.677% |
Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 95.539% |
SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 105.489% |
Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 100.939% |
Mycenax Biotech Inc. | -339.48 Million TWD | 100.287% |
Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 99.896% |
G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 99.025% |
Neith Corporation | -33.61 Million TWD | 102.895% |
Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 100.098% |
TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 156.016% |
TaiRx, Inc. | -208.64 Million TWD | 100.466% |
CHO Pharma, Inc. | -277.73 Million TWD | 100.35% |
EirGenix Inc. | -664.4 Million TWD | 100.146% |
BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 98.683% |
Sunny Pharmtech Inc. | 69.14 Million TWD | 98.593% |
Lin BioScience, Inc. | -1.07 Billion TWD | 100.091% |
BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 100.86% |
Feng Chi Biotech Corp. | 34.83 Million TWD | 97.207% |
Bio Preventive Medicine Corp. | -62.34 Million TWD | 101.561% |
Lukas Biomedical Inc. | -26.3 Million TWD | 103.7% |
RBC Bioscience Corporation | 36.54 Million TWD | 97.338% |
BiOptic Inc. | 65.03 Million TWD | 98.504% |
Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 102.104% |
BRIM Biotechnology, Inc. | -682.46 Million TWD | 100.143% |
Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 102.948% |
Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 101.772% |
Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 99.776% |
Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 101.215% |
NaviFUS Corp. | -55.79 Million TWD | 101.744% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 105.862% |
Sinew Pharma Inc. | -163.63 Million TWD | 100.595% |
Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 101.582% |
Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 99.494% |
Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 100.429% |
AP Biosciences Inc | -325.51 Million TWD | 100.299% |
Medigen Biotechnology Corp. | -1.04 Billion TWD | 100.093% |
3D Global Biotech Inc. | -35.84 Million TWD | 102.714% |
Pharmosa Biopharm Inc. | 29.13 Million TWD | 96.66% |
Intech Biopharm Corporation | -219.58 Million TWD | 100.443% |
Oneness Biotech Co., Ltd. | -674.22 Million TWD | 100.144% |
Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 102.165% |
TWi Biotechnology, Inc. | -160.85 Million TWD | 100.605% |
Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 99.852% |
TCI GENE Inc. | 25.98 Million TWD | 96.255% |
MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 100.879% |
Senhwa Biosciences, Inc. | -283.78 Million TWD | 100.343% |
Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 100.667% |
NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 92.975% |
PharmaEngine, Inc. | 347.3 Million TWD | 99.72% |
Savior Lifetec Corporation | 219.6 Million TWD | 99.557% |
TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 99.435% |
OBI Pharma, Inc. | -855.08 Million TWD | 100.114% |
Meribank Biotech Co., Ltd | -92.56 Million TWD | 101.051% |
Acepodia, Inc. | -764.51 Million TWD | 100.127% |
Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 100.211% |